STOCKHOLDERS' EQUITY (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 5 Months Ended | 6 Months Ended | 7 Months Ended | ||
---|---|---|---|---|---|---|---|
Jan. 31, 2025 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 10, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2024 |
|
Issuance of shares of common stock | 10,632 | 10,632 | 491,186 | ||||
Awards to Non-Employee Directors | 38,378 | 5,382 | |||||
Proceed from issuance of shares of common stock | $ 150,000 | $ 150,000 | $ 1,763,325 | ||||
Research and Development Expense | 479,657 | $ 2,252,325 | 3,248,892 | 2,565,092 | |||
General and Administrative Expense | $ 1,171,137 | $ 5,977,277 | $ 2,610,689 | $ 6,952,851 | |||
Share-Based Compensation in Lieu of Cash | 4,170 | 28,826 | |||||
Vesting Terms of the Restricted Shares | March 31, 2025 | June 10, 2025 | |||||
Value of stock issued in exchange for cash compensation | $ 69,827 | $ 229,753 | |||||
Fair market value per share at grant date | $ 16.74 | $ 7.97 | |||||
Accrued Compensation for Non-Employee Directors | $ 69,827 | $ 124,934 | |||||
Description of shares vested immediately on the date of the award | The restricted shares have been issued to Mr. Yaldoo, 2,691 shares vested immediately on the date of the award, 1,345 shares vested on March 11, 2025, and 1,346 shares will vest on the day prior to the 2025 annual stockholder meeting | ||||||
Additional shares granted for future services | $ 104,819 | ||||||
Private Investors [Member] | |||||||
Issuance of shares of common stock | 3,488 | 83,887 | 3,488 | 140,553 | |||
Proceed from related party | $ 50,000 | $ 659,999 | $ 50,000 | $ 790,781 | |||
Board Of Directors [Member] | |||||||
Share-based compensation | 336,743 | 7,549,655 | 937,288 | 7,661,759 | |||
Research and Development Expense | 19,424 | 2,025,580 | 59,992 | 2,060,228 | |||
General and Administrative Expense | $ 317,319 | $ 5,524,075 | $ 877,296 | $ 5,601,531 | |||
Warrants [Member] | |||||||
Issued | 1,062 | 698 | 1,062 | 698 | |||
Warrants [Member] | Related Party [Member] | |||||||
Issued | 348 | ||||||
Restricted Stock [Member] | |||||||
Fair market value of RSAs vested | $ 3,483,379 | $ 2,355,054 | |||||
Unrecognized compensation expense | $ 0 | $ 1,055,454 | $ 0 | $ 1,055,454 |